SubHero Banner
Text

Flector® (diclofenac epolamine) – Expanded indication and first-time generic (authorized generic)

March 1, 2019 -The FDA announced the approval of Flector (diclofenac epolamine), for the topical treatment of acute pain due to minor strains, sprains, and contusions in adults and pediatric patients 6 years and older.

Download PDF